December 7, 2020 AlzeCure receives approval to start clinical Phase Ib trial with ACD440 in neuropathic pain
November 12, 2020 AlzeCure receives approval to start clinical Phase I trial with ACD856 in Alzheimer’s disease
November 11, 2020 Poster presentation with the Alzstatin platform now available on AlzeCure’s website
October 13, 2020 AlzeCure gets abstract on the NeuroRestore platform against Alzheimer’s accepted for poster presentation at CTAD
October 8, 2020 AlzeCure gets abstract on the Alzstatin platform against Alzheimer’s accepted for poster presentation at CTAD
April 30, 2020 A new doctoral thesis in Alzheimer’s presented today by AlzeCure Pharma and Karolinska Institutet
April 2, 2020 AlzeCure Pharma today presented key preclinical data on its novel cognitive enhancer at the AAT-AD/PD conference
March 16, 2020 AlzeCure Pharma to present late breaking abstract at the AAT-AD/PD conference (Advances in Alzheimer’s and Parkinson’s Therapies)
March 3, 2020 An van Es-Johansson joins management team at AlzeCure Pharma – resigns from Board of Directors
January 7, 2020 AlzeCure Pharma Conducts Strategic Inlicensing of Clinical Phase Drug Candidate for Neuropathic Pain
